Boehringer Ingelheim Vetmedica Launches Buscopan® 20

Boehringer Ingelheim Vetmedica has launched Buscopan® 20mg/ml injection, an antispasmodic treatment for use in cases of equine colic, and an aid to the symptomatic treatment of calf scour. A sister product to Buscopan® Compositum which contains both an antispasmodic and a non-steroidal component, Buscopan 20 contains only the antispasmodic component – hyoscine butylbromide. “Our customers have been telling us for some time that they would really welcome a Buscopan formulation without an NSAID for use in horses and cattle,” says Craig Beck, equine sales and marketing manager at Boehringer Ingelheim Vetmedica. “I’m pleased to say that it’s finally here and I’m sure that Buscopan 20 will be a very welcome addition to the armoury of both equine and cattle practitioners.” Buscopan 20 is supplied in a convenient 50ml multi-dose bottle, and is available in veterinary wholesalers now. For further information, please call 01344 746959.

More from

• CVS relaunches Aspiring General Practitioner Prize in all UK universities
• Mars Veterinary Health underscores long-term commitment to research and innovation in groundbreaking science impact report
• SPILLERS brand makes retailer training fun with new quiz and prizes!
• Organisations Urge MPs to Recognise the Transformative Power of the Human-Companion Animal Bond
• Animal Companionship Charity Our Special Friends appoints Patron and New Trustees to Boost Growth Plans